No recent analyst price targets found for IMUN.
Latest News for IMUN
32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics
NORTH CHICAGO, Ill.--(BUSINESS WIRE)--32 Biosciences to launch $40M Series A at JPM 2026, advancing CS-0003 mucosal-immune therapies for GI SSI and the GB platform.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for IMUN.
U.S. House Trading
No House trades found for IMUN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.